Cargando…
HrHPV testing vs liquid-based cytology in cervical cancer screening among women aged 50 and older: a prospective study
INTRODUCTION: Evidence supports high-risk human papilloma virus (HPV) testing as the primary cervical cancer screening tool. However, benefits and harms should be carefully considered before replacing liquid-based cytology. In women age 50 and older, we evaluated how a commercially available DNA amp...
Autores principales: | Andersen, Berit, Njor, Sisse Helle, Jensen, Anne Marie Schak, Johansen, Tonje, Jeppesen, Ulla, Svanholm, Hans |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7656146/ https://www.ncbi.nlm.nih.gov/pubmed/33037107 http://dx.doi.org/10.1136/ijgc-2020-001457 |
Ejemplares similares
-
Long-term CIN3+ risk in women with abnormal cytology; role of hrHPV testing
por: Kocken, M, et al.
Publicado: (2012) -
hrHPV E5 oncoprotein: immune evasion and related immunotherapies
por: de Freitas, Antonio Carlos, et al.
Publicado: (2017) -
Longitudinal analysis on the ecological dynamics of the cervicovaginal microbiome in hrHPV infection
por: Molina, Mariano A., et al.
Publicado: (2023) -
Prevalence and risk factors for High-Risk Human Papillomavirus (hrHPV) infection among HIV-infected and Uninfected Rwandan women: implications for hrHPV-based screening in Rwanda
por: Sinayobye, Jean d’Amour, et al.
Publicado: (2014) -
LINE-1 and Alu Methylation in hrHPV-Associated Precancerous Cervical Samples
por: Chaiwongkot, Arkom, et al.
Publicado: (2022)